The Union Cycliste Internationale (UCI) announces that the Colombian rider Jarlinson Pantano Gomez was notified of an Adverse Analytical Finding (AAF) of Erythropoietin in a sample collected during an out-of-competition control on 26 February 2019.
The control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.
The rider has the right to request and attend the analysis of the B sample.
In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair.
At this stage of the procedure, the UCI will not comment any further on this matter.